Compare MAXN & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAXN | NEPH |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 31.0M |
| IPO Year | 2019 | 2004 |
| Metric | MAXN | NEPH |
|---|---|---|
| Price | $0.79 | $3.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.8M | 21.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1000.00 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $18,789,000.00 |
| Revenue This Year | $100.37 | $11.24 |
| Revenue Next Year | $24.61 | $11.58 |
| P/E Ratio | ★ N/A | $28.23 |
| Revenue Growth | N/A | ★ 32.67 |
| 52 Week Low | $0.67 | $1.88 |
| 52 Week High | $4.97 | $6.42 |
| Indicator | MAXN | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 29.44 | 54.94 |
| Support Level | $0.67 | $2.77 |
| Resistance Level | $3.78 | $4.26 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 7.90 | 79.05 |
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.